Related content

A Phase II Study of Doxorubicin, Cisplatin, and 5-Fluorouracil in Patients with Advanced Adenocarcinoma of the Stomach or Esophagus

By Kulke Matthew   Wu Bingyan   Clark Jeffrey   Enzinger Peter   Lynch Thomas   Vincitore Michele   Michelini Ann   Fuchs Charles  

Cancer Investigation, Vol. 24, Iss. 3, 2006-05 ,pp. : 229-234

Informa Healthcare

Access to resources Recommend Favorite

Neoadjuvant Chemotherapy Using Low-Dose Consecutive Intraarterial Infusions of Cisplatin Combined with 5-Fluorouracil for Locally Advanced Cervical Adenocarcinoma

By Aoki Y.   Sato T.   Watanabe M.   Sasaki M.   Tsuneki I.   Tanaka K.  

Gynecologic Oncology, Vol. 81, Iss. 3, 2001-06 ,pp. : 496-499

Elsevier

Access to resources Recommend Favorite

Tailored preoperative treatment of locally advanced triple negative (hormone receptor negative and HER2 negative) breast cancer with epirubicin, cisplatin, and infusional fluorouracil followed by weekly paclitaxel

By Torrisi Rosalba  

Cancer Chemotherapy and Pharmacology, Vol. 62, Iss. 4, 2008-09 ,pp. : 667-672

Springer Publishing Company

Access to resources Recommend Favorite

The efficacy and safety of reduced-dose docetaxel, cisplatin, and 5-fluorouracil in the first-line treatment of advanced stage gastric adenocarcinoma

By Özdemir Nuriye   Abalı Hüseyin   Öksüzoğlu Berna   Budakoglu Burçin   Uncu Doğan   Güler Tunç   Odabaşı Hatice   Zengin Nurullah  

Medical Oncology, Vol. 27, Iss. 3, 2010-09 ,pp. : 680-684

Humana Press, Inc

Access to resources Recommend Favorite

5-Fluorouracil and cisplatin in the treatment of advanced oral cancer

By Andreadis C.   Vahtsevanos K.   Sidiras T.   Thomaidis I.   Antoniadis K.   Mouratidou D.  

Oral Oncology, Vol. 39, Iss. 4, 2003-06 ,pp. : 380-385

Elsevier

Access to resources Recommend Favorite